{
    "2019-04-20": [
        [
            {
                "time": "",
                "original_text": "恒瑞2019Q1成绩单：营收49.6亿增长28.8%，研发6.6亿，这些重磅品种将大获丰收",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "2019Q1",
                        "营收",
                        "增长",
                        "研发",
                        "重磅品种"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【天风医药】长春高新：一季度延续高增长态势，购买金赛少数股权值得期待",
                "features": {
                    "keywords": [
                        "天风医药",
                        "长春高新",
                        "一季度",
                        "高增长",
                        "金赛",
                        "少数股权"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}